Metaformin use may decrease use of pancreatic cancer


August 4, 2009

Reuters Health

NEW YORK (Reuters Health) - Use of metformin is associated with a decreased risk of pancreatic cancer in patients with diabetics, new research shows. By contrast, treatment with insulin or an insulin secretagogue may increase the risk.

"The current study demonstrated a robust protective effect of metformin against pancreatic cancer in diabetes. Our major observations were that diabetics who ever used metformin, especially those with greater than five years of use, had a reduced risk of pancreatic cancer compared to diabetics who had not taken these drugs," lead author Dr. Donghui Li said in a statement... Read More